Antiplatelet Therapy in High Bleeding Risk Patients Following Complex PCI: A HOST-BR Trial Sub-Study

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Grant Support/Research Contract - Daiichi-Sankyo/Elil Lilly and Company; Terumo Medical Corporation; Biotronik; Medtronic; Abbott Vascular</li></ul>